MG98: Phase I data; Phase II

Interim results from Phase I dose escalation trials showed that 1 patient with

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE